The FDA approved a subcutaneous (SC) induction regimen of guselkumab (Tremfya, Johnson & Johnson) for adults with moderately to severely active ulcerative colitis (UC). Guselkumab is the first and ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a subcutaneous induction regimen of guselkumab for the treatment of adults with moderately ...

The Microscopic and Digital One-Day-Dentistry Concept is a new and cutting-edge workflow, first time published by Dr. Behnam Shakibaie and his research team at the University of Pennsylvania, that ...

FS1’s Wake Up Barstool is a work in progress. But by the time the show becomes the finished article, there may be nobody left to see it. When the show debuted earlier this month, it was unlike ...

A toxic protein forms dynamic pores in the membranes of brain cells—and that may be the key to understanding how Parkinson's disease develops. This is the conclusion of a new study from Aarhus ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

The hottest engine in the world is minuscule, reaches seemingly impossible efficiencies and could approximate nature’s tiniest machines. They used an electric field to trap and levitate the bead in a ...

Both ulcerative colitis and Crohn's are inflammatory bowel diseases (IBDs) so the idea that smoking would help one but hurt the other has been confounding. Colitis causes an inflammation of the colon ...

Various factors may increase risk for microscopic colitis — NSAIDs among them. Risk factors including nonsteroidal anti-inflammatory drugs (NSAIDs), statins, proton pump inhibitors (PPIs), and smoking ...

Researchers led by Hiroshi Ohno at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have discovered why smoking tobacco helps people suffering from ulcerative colitis, a chronic ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — An experimental oral treatment from Abivax helped ease symptoms ...

Topline data were announced from two phase 3 trials evaluating obefazimod in adults with moderately to severely active ulcerative colitis (UC). Obefazimod is an oral small molecule drug that is ...